Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,545 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Assessing the Efficacy of Bortezomib and Dexamethasone for Induction and Maintenance Therapy in Relapsed/Refractory Cutaneous T-Cell Lymphoma: A Phase II CISL1701/BIC Study.
Choi YS, Shim J, Kang KW, Yoon SE, Hong JS, Lim SN, Yhim HY, Kwon JH, Lee GW, Yang DH, Oh SY, Shin HJ, Eom HS, Yoon DH, Lee HG, Jeong SH, Kim WS, Kim SJ. Choi YS, et al. Among authors: lee hg, lee gw. Cancer Res Treat. 2025 Jan;57(1):267-279. doi: 10.4143/crt.2024.479. Epub 2024 Jul 16. Cancer Res Treat. 2025. PMID: 39010796 Free PMC article. Clinical Trial.
Efficacy and safety of blinatumomab treatment in adult Korean patients with relapsed/refractory acute lymphoblastic leukemia on behalf of the Korean Society of Hematology ALL Working Party.
Jung SH, Lee SR, Yang DH, Lee S, Yoon JH, Lee H, Bang SM, Koh Y, Park S, Kim DS, Yhim HY, Kim SH, Lee JH, Sohn SK, Song IC, Lee HG, Cheong JW, Choi Y, Shin HJ. Jung SH, et al. Among authors: lee h, lee sr, lee hg, lee jh, lee s. Ann Hematol. 2019 Jan;98(1):151-158. doi: 10.1007/s00277-018-3495-2. Epub 2018 Sep 26. Ann Hematol. 2019. PMID: 30259121 Clinical Trial.
Oral HDAC inhibitor tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Yokoyama M, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Shibayama H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: lee js, lee ws, lee hg, lee jh. Haematologica. 2023 Mar 1;108(3):811-821. doi: 10.3324/haematol.2022.280996. Haematologica. 2023. PMID: 36200417 Free PMC article.
Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia.
Kim DY, Joo YD, Lim SN, Kim SD, Lee JH, Lee JH, Kim DH, Kim K, Jung CW, Kim I, Yoon SS, Park S, Ahn JS, Yang DH, Lee JJ, Lee HS, Kim YS, Mun YC, Kim H, Park JH, Moon JH, Sohn SK, Lee SM, Lee WS, Kim KH, Won JH, Hyun MS, Park J, Lee JH, Shin HJ, Chung JS, Lee H, Eom HS, Lee GW, Cho YU, Jang S, Park CJ, Chi HS, Lee KH; Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology. Kim DY, et al. Blood. 2015 Aug 6;126(6):746-56. doi: 10.1182/blood-2015-03-636548. Epub 2015 Jun 11. Blood. 2015. PMID: 26065651 Free article. Clinical Trial.
Long-term efficacy and safety of tucidinostat in patients with relapsed or refractory peripheral T-cell lymphoma: final analysis of phase IIb results.
Rai S, Kim WS, Ando K, Choi I, Izutsu K, Tsukamoto N, Maruyama D, Tsukasaki K, Kuroda J, Ando J, Hidaka M, Koh Y, Kato H, Uchida T, Yang DH, Ishitsuka K, Ishizawa K, Kim JS, Lee HG, Minami H, Eom HS, Kurosawa M, Lee JH, Lee JS, Lee WS, Nagai H, Shindo T, Yoon DH, Yoshida S, Gillings M, Onogi H, Tobinai K. Rai S, et al. Among authors: lee js, lee ws, lee hg, lee jh. Haematologica. 2024 Oct 1;109(10):3357-3362. doi: 10.3324/haematol.2023.283992. Haematologica. 2024. PMID: 38841789 Free PMC article. Clinical Trial. No abstract available.
Optimizing Preparative Regimen for Umbilical Cord Blood Transplantation in Adult Acute Leukemia Patients: Acute Lymphoblastic Leukemia Requires Myeloablative Conditioning but Not Acute Myeloid Leukemia.
Byun JM, Hong J, Oh D, Yhim HY, Do YR, Park JS, Jung CW, Yang DH, Won JH, Lee HG, Moon JH, Mun YC, Jo DY, Han JJ, Lee JH, Lee JH, Lee J, Yoon SS. Byun JM, et al. Among authors: lee j, lee hg, lee jh. J Clin Med. 2020 Jul 21;9(7):2310. doi: 10.3390/jcm9072310. J Clin Med. 2020. PMID: 32708168 Free PMC article.
Adenocarcinoma of unknown primary site.
Song SY, Kim WS, Lee HR, Jung HS, Oh SY, Kim JH, Kim K, Nam EM, Oh YR, Jung CW, Yoon SS, Im YH, Lee HG, Kang WK, Park CH, Park K. Song SY, et al. Among authors: lee hr, lee hg. Korean J Intern Med. 2002 Dec;17(4):234-9. doi: 10.3904/kjim.2002.17.4.234. Korean J Intern Med. 2002. PMID: 12647637 Free PMC article.
Prediction of survival by applying current prognostic models in diffuse large B-cell lymphoma treated with R-CHOP followed by autologous transplantation.
Lee HG, Kim SY, Kim I, Kim YK, Kim JA, Kim YS, Lee HS, Park J, Kim SJ, Shim H, Eom HS, Park BB, Lee J, Park SK, Cheong JW, Park KW. Lee HG, et al. Among authors: lee hs, lee j. Blood Res. 2015 Sep;50(3):160-6. doi: 10.5045/br.2015.50.3.160. Epub 2015 Sep 22. Blood Res. 2015. PMID: 26457283 Free PMC article.
Clinical Features and Survival of Patients With Follicular Lymphoma in Korea.
Cho SH, Suh C, Do YR, Lee JJ, Yun HJ, Oh SY, Lee HS, Cho SG, Cho IS, Lee WS, Won YW, Kim HJ, Lee HG, Lee SI, Lim SN, Sohn BS, Ahn HJ, Chang MH, Kwon KA, Kim WS. Cho SH, et al. Among authors: lee si, lee hs, lee ws, lee hg, lee jj. Clin Lymphoma Myeloma Leuk. 2016 Apr;16(4):197-202. doi: 10.1016/j.clml.2015.12.012. Epub 2016 Jan 6. Clin Lymphoma Myeloma Leuk. 2016. PMID: 26850215
1,545 results